Press "Enter" to skip to content

Cannabis Companies with Publicly Traded Stocks

Image result for GW PharmaceuticalsGW Pharmaceuticals

Company gwpharm.com

GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis treatment product Sativex, nabiximols. Sativex is the first natural cannabis plant derivative to gain market approval in any country. Wikipedia
Stock price: GWPH (NASDAQ) $119.78 +0.28 (+0.23%)
Mar 23, 9:38 AM EDT – Disclaimer
Founded: 1998
CEO: Justin Gover (Jan 1999–)

GW is the global leader in developing cannabinoid-based medicines. … London, UK, 7 March 2017: GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the …

The Investor Relations website contains information about GW Pharmaceuticals Plc business for stockholders, potential investors, and financial analysts.

About Us | GW Pharmaceuticals, plc

https://www.gwpharm.com/about-us
GW has established a world leading position in the development of plant-derived cannabinoid therapeutics through its proven drug discovery and development …

Forget GW Pharmaceuticals — These 2 Stocks Are Better Buys — The …

https://www.fool.com/…/02/…/forget-gw-pharmaceuticals-these-2-stocks-are-bette.asp…
Feb 2, 2017 – Britain’s GW Pharmaceuticals (NASDAQ:GWPH) has certainly captured the market’s imagination with its cannabidiol drug development …

Why You Should (and Shouldn’t) Buy GW Pharmaceuticals Plc — The …

https://www.fool.com/…/why-you-should-and-shouldnt-buy-gw-pharmaceuticals.aspx
Aug 26, 2016 – GW Pharmaceuticals trounced its biopharma peers this year. Is it still a buy?

Better Marijuana Stock to Buy: GW Pharmaceuticals or Insys …

https://www.fool.com/…/better-marijuana-stock-to-buy-gw-pharmaceuticals-o.aspx
Feb 4, 2017 – Fortunately, GW Pharmaceuticals and Insys Therapeutics are conducting those studies to prove that marijuana-based drugs can be a better …

3 Reasons GW Pharmaceuticals Stock Could Rise — The Motley Fool

https://www.fool.com/investing/…/3-reasons-gw-pharmaceuticals-stock-could-rise.asp…
Jan 22, 2017 – Repeated clinical success drove shares of GW Pharmaceuticals (NASDAQ:GWPH) about 60% higher in 2016, and an impressive 190% higher …
View the basic GWPH stock chart on Yahoo Finance. Change the date range, chart type and compare GW Pharmaceuticals Plc against other companies.

GW Pharmaceuticals: Could A Blockbuster Cannabis Drug Be On The …

seekingalpha.com › Investing Ideas › Long Ideas › Healthcare
Feb 13, 2017 – The medical cannabis market in America is a huge growth opportunity many investors are overlooking. GW’s Epidiolex is currently in Phase 3 …